A clinical research committee is evaluating a newly developed quantitative immunoassay that detects a circulating tumor biomarker for early pancreatic adenocarcinoma. The current diagnostic threshold for a positive test is set at 150 ng/mL. In an effort to minimize the number of missed early-stage malignancies, the committee decides to adjust the threshold for a positive result to 75 ng/mL. When implemented in the same screening population, which of the following pairs of statistical parameters will most likely both decrease as a direct result of this threshold adjustment?
- ASensitivity and positive predictive value
- BSpecificity and negative predictive value
- False-negative rate and positive predictive valueAnswer
- DFalse-positive rate and negative predictive value
- ETrue-negative rate and false-positive rate
Answer
The false-negative rate and positive predictive value will both decrease.
Lowering the diagnostic threshold (from 150 ng/mL to 75 ng/mL) means a lower concentration of the biomarker is required for a positive result. This change makes the test more 'sensitive,' correctly identifying more patients who actually have the disease (increased true positives) and missing fewer patients with the disease (decreased false negatives). Consequently, the false-negative rate decreases. However, it will also incorrectly label more healthy individuals as having the disease (increased false positives). Because the number of false positives increases, the proportion of positive test results that are truly positive drops, leading to a decreased positive predictive value (PPV). Therefore, both the false-negative rate and the positive predictive value decrease.
Step-by-Step Solution
Key Concept
Effect of shifting diagnostic thresholds on test characteristics
Estimated Time:1m 30s